Emergency Medicine
Emergency
High Evidence

Rhabdomyolysis

Life-threatening muscle breakdown syndrome (CK greater than 1,000 U/L) from trauma, drugs, exertion, or seizures causing... ACEM Primary Written, ACEM Primary V

Updated 24 Jan 2026
49 min read

Clinical board

A visual summary of the highest-yield teaching signals on this page.

Urgent signals

Safety-critical features pulled from the topic metadata.

  • CK greater than 5,000 U/L with AKI (Cr greater than 177 µmol/L or 2.0 mg/dL)
  • Dark brown/tea-coloured urine (myoglobinuria)
  • Compartment syndrome (tense, painful muscle compartments)
  • Hyperkalaemia greater than 6.0 mmol/L (risk of cardiac arrest)

Exam focus

Current exam surfaces linked to this topic.

  • ACEM Primary Written
  • ACEM Primary Viva
  • ACEM Fellowship Written
  • ACEM Fellowship OSCE

Linked comparisons

Differentials and adjacent topics worth opening next.

  • Acute Kidney Injury
  • Hyperkalaemia

Editorial and exam context

ACEM Primary Written
ACEM Primary Viva
ACEM Fellowship Written
ACEM Fellowship OSCE

Topic family

This concept exists in multiple MedVellum libraries. Use the primary page for the broadest reference view and the others for exam-specific framing.

Clinical reference article

Quick Answer

One-liner: Rhabdomyolysis is breakdown of skeletal muscle releasing myoglobin and creatine kinase, causing myoglobinuria and acute kidney injury requiring aggressive IV fluid resuscitation.

Life-threatening muscle breakdown syndrome (CK greater than 1,000 U/L) from trauma, drugs, exertion, or seizures causing myoglobinuria (tea-coloured urine), hyperkalaemia, and AKI. Mortality 5-10% overall, 30% with AKI. Immediate management: aggressive IV fluid resuscitation 200-300 mL/h targeting urine output greater than 200-300 mL/h to prevent myoglobin-induced tubular injury. Monitor for compartment syndrome (fasciotomy if compartment pressures greater than 30 mmHg), severe electrolyte disturbances (hyperkalaemia, hypocalcaemia, hyperphosphataemia), and dialysis-requiring AKI.


ACEM Exam Focus

Primary Exam Relevance

  • Anatomy: Skeletal muscle structure, nephron anatomy (proximal tubule injury), compartment anatomy
  • Physiology: Muscle metabolism, myoglobin structure and renal handling, acid-base homeostasis, potassium homeostasis
  • Pharmacology: Statins, fibrates, antipsychotics, illicit drugs (amphetamines, cocaine, MDMA), alcohol
  • Pathology: Muscle cell lysis, myoglobin tubular cast formation, acute tubular necrosis

Fellowship Exam Relevance

  • Written: High-yield topic - fluid resuscitation protocols, indications for bicarbonate/mannitol (controversial), dialysis criteria, compartment syndrome diagnosis
  • OSCE: Likely scenarios - crush injury management, drug-induced rhabdomyolysis assessment, breaking bad news (amputation/dialysis), procedure (fasciotomy discussion)
  • Key domains tested: Medical Expert (fluid resuscitation, electrolyte management), Communicator (family discussion), Leader (multidisciplinary coordination)

Key Points

Clinical Pearl

The 5 things you MUST know:

  1. CK threshold: CK greater than 1,000 U/L (5× ULN) defines rhabdomyolysis; severe if greater than 5,000 U/L or greater than 15,000 U/L (high AKI risk)
  2. Triad: Muscle pain/weakness + myoglobinuria (dark urine) + elevated CK (though triad only present in 10%)
  3. Aggressive fluids: 200-300 mL/h IV normal saline initially, targeting urine output greater than 200-300 mL/h until myoglobinuria clears
  4. AKI risk: 13-50% develop AKI; peak risk with CK greater than 5,000 U/L, volume depletion, sepsis, acidosis
  5. Electrolyte disasters: Hyperkalaemia (muscle release), hypocalcaemia (muscle calcium deposition), hyperphosphataemia (muscle release) - all can be life-threatening

Epidemiology

MetricValueSource
Incidence26,000 cases/year (USA), 1-5% of AKI admissions[1] PMID: 23860505
ED incidence~0.06% of ED presentations[2] PMID: 23860505
AKI development13-50% (varies by severity)[3] PMID: 23860505
Mortality5-10% overall, up to 30% with AKI[4] PMID: 25066782
Peak age20-60 years (trauma/exertion), older with statins[5] PMID: 23860505
Gender ratioM:F 2-3:1 (trauma, exertion predominate)[6] PMID: 23860505

Australian/NZ Specific

  • Higher incidence in remote areas from heat-related exertion (mining, agriculture, military)
  • Indigenous populations: 2-3× higher incidence due to higher rates of trauma, substance use, heat exposure in remote regions (AIHW data)
  • Seasonal variation: Summer peak (exertional heat stroke), winter peak (immobility/falls in elderly)
  • Envenomation: Sea snake bites (Australian waters), Tiger snake (myotoxic venom) rare causes

Pathophysiology

Mechanism

1. Muscle Cell Injury

  • Disruption of sarcolemma → loss of ATP-dependent Na⁺/K⁺-ATPase function
  • Intracellular calcium influx → activation of proteases and phospholipases
  • Mitochondrial dysfunction → further ATP depletion → cell death

2. Release of Muscle Contents

Myoglobin + CK + Potassium + Phosphate + Uric acid + Purines

3. Myoglobin-Induced Nephrotoxicity (PMID: 12631547)

  • Direct tubular toxicity: Myoglobin breakdown → ferrihemate release → hydroxyl radical formation
  • Tubular obstruction: Myoglobin precipitates as casts in acidic urine (pH below 5.6) in distal tubule
  • Renal vasoconstriction: Volume depletion + myoglobin → intrarenal vasoconstriction → ischaemic ATN
  • Inflammation: Release of inflammatory mediators from damaged muscle

4. Electrolyte Disturbances

  • Early phase (0-48h): Hyperkalaemia (K⁺ release), hyperphosphataemia (PO₄³⁻ release), hypocalcaemia (Ca²⁺ deposition in damaged muscle)
  • Recovery phase (3-7 days): Hypercalcaemia (Ca²⁺ mobilization from muscle), hypomagnesaemia

Pathological Progression

Muscle injury → Cell lysis → Myoglobin/CK release → Hypovolaemia + Acidic urine → Myoglobin precipitation in tubules → Acute tubular necrosis → AKI

Why It Matters Clinically

  • Fluid resuscitation prevents AKI by maintaining high urine flow (flushes myoglobin), diluting myoglobin, improving renal perfusion
  • Alkaline urine (controversial) may prevent myoglobin precipitation (soluble at pH greater than 6.5)
  • Hyperkalaemia can cause sudden cardiac arrest - requires immediate treatment if greater than 6.0 mmol/L
  • Compartment syndrome perpetuates muscle injury → positive feedback loop

Clinical Approach

Recognition

High Index of Suspicion in:

  • Trauma: Crush injury, prolonged immobilisation (fall, overdose), electrical injury, burns
  • Drugs/toxins: Statins, fibrates, cocaine, amphetamines, MDMA, alcohol, antipsychotics
  • Exertion: Marathon, military training, heat stroke, seizures (prolonged or status)
  • Infections: Influenza, sepsis, necrotising fasciitis, gas gangrene
  • Metabolic: DKA, thyroid storm, electrolyte disorders (hyponatraemia, hypokalaemia)

Initial Assessment

Primary Survey

  • A (Airway): Usually patent unless decreased GCS (seizure, overdose, trauma)
  • B (Breathing): Often normal; assess for aspiration pneumonia (prolonged immobilisation), pulmonary oedema (fluid overload in AKI)
  • C (Circulation):
    • "Hypovolaemia common (third-spacing into damaged muscle): tachycardia, hypotension"
    • "Hyperkalaemia: Bradycardia, wide-complex rhythms, cardiac arrest risk"
    • Assess volume status (JVP, peripheral perfusion, cap refill)
  • D (Disability):
    • GCS (overdose, trauma, post-ictal)
    • Muscle pain/weakness assessment
    • "Check compartments (5 Ps: Pain, Pressure, Paraesthesias, Pallor, Pulselessness)"
  • E (Exposure):
    • Examine all muscle groups (tenderness, swelling)
    • "Skin: needle marks (IV drug use), burns, pressure sores"
    • "Temperature: hypothermia (immobilisation) vs hyperthermia (heat stroke, serotonin syndrome, NMS)"

History

Key Questions

QuestionSignificance
"What were you doing when symptoms started?"Exertion, trauma, immobilisation, overdose
"Have you taken any medications or drugs?"Statins, fibrates, antipsychotics, cocaine, MDMA
"When did you last pass urine? What colour was it?"Oliguria (AKI), dark/tea-coloured (myoglobinuria)
"Do you have muscle pain? Where?"Focal (compartment syndrome) vs generalised
"Any recent illness/fever?"Influenza (PMID: 19453597), sepsis, necrotising infection
"Any recent seizures or falls?"Prolonged seizure, immobilisation from fall
"Any previous episodes?"Recurrent rhabdomyolysis: metabolic myopathy (CPT2, McArdle disease)

Red Flag Symptoms

Red Flag
  • Dark brown/tea-coloured urine (myoglobinuria - indicates severe rhabdomyolysis)
  • Severe muscle pain with tense, swollen compartments (compartment syndrome - requires urgent fasciotomy)
  • Oliguria or anuria (developing AKI)
  • Chest pain/palpitations (hyperkalaemia → arrhythmia)
  • Confusion/decreased GCS (uraemia, hypercalcaemia in recovery phase)

Examination

General Inspection

  • Level of consciousness: Alert vs drowsy/confused (uraemia, drug intoxication, hypercalcaemia)
  • Volume status: Dry mucous membranes, reduced skin turgor (hypovolaemia common)
  • Muscle bulk: Swelling vs wasting
  • Urine colour: Dark brown/tea-coloured (myoglobinuria) vs normal yellow

Specific Findings

SystemFindingSignificance
MusculoskeletalMuscle tenderness, swellingLocalised injury, compartment syndrome risk
Tense compartments (5 Ps)EMERGENCY - fasciotomy required
Muscle weaknessSeverity of muscle damage, K⁺ disturbance
CardiovascularTachycardiaHypovolaemia, pain, hyperkalaemia
Bradycardia, wide-complex QRSSevere hyperkalaemia - impending arrest
RenalOliguria (below 0.5 mL/kg/h)AKI development
Peripheral oedemaFluid overload in oliguric AKI
SkinPressure sores, burnsImmobilisation duration
Needle track marksIVDU (cocaine, amphetamines)
NeurologicalConfusion, asterixisUraemia (severe AKI)

Investigations

Immediate (Resus Bay)

TestPurposeKey Finding
ECGHyperkalaemia screeningTall peaked T waves, wide QRS, loss of P waves, sine wave → arrest
VBG/ABGK⁺, pH, lactateK⁺ greater than 6.0 mmol/L (treat immediately), acidosis common, lactate elevated
Point-of-care glucoseRule out DKAHyperglycaemia may trigger DKA (precipitant)
Urine dipstickMyoglobinuriaBlood +++ on dipstick but NO RBCs on microscopy = myoglobinuria

Standard ED Workup

TestIndicationInterpretation
Creatine kinase (CK)Diagnostic, severitygreater than 1,000 U/L (diagnostic), greater than 5,000 U/L (severe, high AKI risk), greater than 15,000 U/L (very high AKI risk ~50%) [7] PMID: 23860505
Creatinine + eGFRAKI assessmentCr greater than 177 µmol/L (2.0 mg/dL) or rising = AKI. Peak Cr usually 3-5 days post-injury
ElectrolytesK⁺, Ca²⁺, PO₄³⁻Hyperkalaemia (life-threatening), hypocalcaemia (early), hyperphosphataemia (muscle release)
FBCAnaemia, infectionHaemoconcentration (hypovolaemia), leucocytosis (stress, infection)
CoagulationDIC screeningProlonged PT/aPTT, low fibrinogen, elevated D-dimer (DIC in severe cases)
LFTsHepatic involvementTransaminases elevated (AST/ALT from muscle, not liver - check GGT/bilirubin to differentiate)
Urinalysis + microscopyMyoglobinuriaBlood +++ on dipstick, below 5 RBCs/hpf on microscopy (myoglobin cross-reacts with dipstick haem test)
Serum myoglobinIf urine negativeRapidly cleared by kidneys; normal myoglobin does not exclude rhabdomyolysis
Lactate dehydrogenase (LDH)Alternative markerElevated, correlates with CK but less specific
Urine myoglobinConfirmationIf available, confirms myoglobinuria (turns urine brown)
Toxicology screenIllicit drugsAmphetamines, cocaine, MDMA (common causes)

Advanced/Specialist

TestIndicationAvailability
Compartment pressure monitoringSuspected compartment syndromeIntra-compartmental pressure greater than 30 mmHg absolute or below 30 mmHg delta (diastolic BP - compartment pressure) = fasciotomy
Muscle biopsyRecurrent rhabdomyolysisTertiary center - metabolic myopathy workup (CPT2, McArdle, mitochondrial)
Genetic testingFamily history, recurrentCPT2 deficiency, myophosphorylase deficiency (McArdle), malignant hyperthermia susceptibility
CT imagingMuscle edema assessmentNot routine, may show muscle swelling/necrosis in severe crush injury

Point-of-Care Ultrasound

Applications:

  • Volume status assessment: IVC diameter and collapsibility (guide fluid resuscitation)
  • Bladder scan: Confirm oliguria vs urinary retention
  • FAST scan: If trauma (concurrent intra-abdominal injury)
  • Muscle edema: Increased echogenicity, loss of normal architecture (not standard practice)

Management

Immediate Management (First 10 minutes)

1. STOP nephrotoxic drugs (statins, NSAIDs, ACE-I/ARB, contrast) [0-5 min]
2. Establish large-bore IV access (×2 if severe) [0-5 min]
3. Start aggressive IV fluid resuscitation: 0.9% NaCl 1-2 L bolus, then 200-400 mL/h [5-10 min] (PMID: 23860505)
4. ECG and VBG - treat hyperkalaemia if K⁺ greater than 6.0 mmol/L or ECG changes [5-10 min]
5. Insert IDC - monitor hourly urine output (target greater than 200-300 mL/h initially) [10-15 min]
6. Bloods: CK, creatinine, electrolytes, Ca²⁺, PO₄³⁻, FBC, coags [10 min]

Resuscitation (if applicable)

Airway

  • Maintain airway if decreased GCS (post-seizure, overdose)
  • Intubate if GCS below 8, inability to protect airway, severe metabolic acidosis requiring ventilatory support

Breathing

  • Oxygen: Maintain SpO₂ greater than 94%
  • Ventilation: If intubated, target pH 7.35-7.45 (acidosis worsens hyperkalaemia)

Circulation

Fluid Resuscitation - Cornerstone of Management (PMID: 23860505, PMID: 12631547)

PhaseGoalFluid TypeRateMonitoring
Initial (0-6h)Restore intravascular volume0.9% NaCl1-2 L bolus, then 200-400 mL/hUO, vital signs, volume status
Maintenance (6-72h)Urine output greater than 200-300 mL/h until myoglobinuria clears0.9% NaClTitrate to UO (may need 500-1,000 mL/h)Hourly UO, fluid balance, Cr, CK, electrolytes q6-12h
Ongoing (72h+)Urine output greater than 0.5 mL/kg/h0.9% NaClReduce to 100-200 mL/hDaily Cr, CK, electrolytes

Key Points:

  • Goal: Maintain high urine flow to flush myoglobin from tubules before precipitation
  • Avoid: Lactated Ringer's (contains potassium, theoretical concern)
  • Monitor carefully: Elderly, cardiac disease at risk of pulmonary oedema
  • Fluid overload: If develops → ICU, consider dialysis

Hyperkalaemia Management

If K⁺ greater than 6.0 mmol/L or ECG changes (PMID: 33471519)

TreatmentDoseOnsetDurationIndication
Calcium gluconate 10%10-20 mL IV over 2-5 min1-3 min30-60 minCardioprotection if ECG changes (repeat if needed)
Insulin + Dextrose10 units insulin + 25 g (50 mL 50%) dextrose IV15-30 min4-6 hoursShift K⁺ intracellular (lowers K⁺ by 0.5-1.2 mmol/L)
Salbutamol10-20 mg nebulised30 min2-4 hoursShift K⁺ intracellular (adjunct to insulin)
Sodium bicarbonate50-100 mmol (50-100 mL 8.4%) IV over 15-30 min30-60 min2-4 hoursOnly if pH below 7.2 (acidosis worsens hyperkalaemia)
Resonium/Kayexalate15-30 g PO/PR2-4 hours6-12 hoursRemove K⁺ from body (slow onset, controversial efficacy)
DialysisHaemodialysisImmediateDuration of dialysisDefinitive for refractory hyperkalaemia (K⁺ greater than 7.0 mmol/L unresponsive to medical therapy)

Medications

DrugDoseRouteTimingNotes
0.9% NaCl200-400 mL/h (titrate to UO)IVImmediateFirst-line therapy. Target UO greater than 200-300 mL/h until myoglobinuria clears
Sodium bicarbonate 8.4%50-100 mmol IV (only if pH below 6.5)IVConsider if severe acidosisCONTROVERSIAL. May prevent myoglobin precipitation (soluble pH greater than 6.5) [8] PMID: 23860505. Risk: hypocalcaemia worsening
Mannitol0.5-1 g/kg IV (only if urine output inadequate)IVSecond-lineCONTROVERSIAL. Osmotic diuresis. Risk: volume overload, AKI worsening [9] PMID: 23860505. Not recommended routinely
Furosemide20-40 mg IVIVOnly if fluid overloadAVOID unless volume overload. May worsen AKI if hypovolaemic
Calcium gluconate 10%10-20 mL IV over 2-5 minIVIf K⁺ greater than 6.0 or ECG changesCardioprotection (does not lower K⁺)
Insulin + Dextrose10 units + 25 g dextrose IVIVIf K⁺ greater than 6.0 mmol/LLowers K⁺ by 0.5-1.2 mmol/L
Rasburicase0.15-0.2 mg/kg IVIVOnly if severe hyperuricaemiaRecombinant urate oxidase. Rare indication (tumour lysis-like syndrome)

Paediatric Dosing

DrugDoseMaxNotes
0.9% NaCl20 mL/kg bolus, then 10-20 mL/kg/hTitrate to UOTarget UO greater than 2 mL/kg/h initially
Calcium gluconate 10%0.5-1 mL/kg IV over 5 min20 mLIf hyperkalaemia with ECG changes
Insulin + Dextrose0.1 units/kg + 0.5-1 g/kg dextrose10 unitsLower K⁺ by 0.5-1.2 mmol/L

Ongoing Management

Monitoring (First 24-48h):

  • Hourly: Urine output (target greater than 200-300 mL/h until myoglobinuria clears), vital signs
  • 4-6 hourly: VBG (K⁺, pH, lactate), creatinine, CK
  • 12-24 hourly: Electrolytes (K⁺, Ca²⁺, PO₄³⁻), fluid balance
  • Daily: FBC, coagulation (if severe)

CK Trends:

  • CK peaks at 24-72h post-injury
  • CK halves every 24-48h with adequate hydration
  • Persistent rise or plateau → ongoing muscle injury (compartment syndrome, infection)

Urine Colour:

  • Dark brown/tea-coloured → myoglobinuria present
  • Clear yellow → myoglobinuria cleared (can reduce fluid rate to maintain UO greater than 0.5 mL/kg/h)

Compartment Syndrome Surveillance (PMID: 28459823)

  • Serial examinations (5 Ps: Pain, Pressure, Paraesthesias, Pallor, Pulselessness)
  • Pain out of proportion to injury is earliest sign
  • Passive stretch of compartment muscles worsens pain
  • If suspected → urgent orthopaedic consult for pressure measurement/fasciotomy

Electrolyte Management:

  • Hyperkalaemia: Repeat insulin/dextrose, salbutamol as needed; dialysis if refractory
  • Hypocalcaemia: Usually asymptomatic; AVOID calcium replacement in early phase unless symptomatic (tetany, seizures) → may worsen metastatic calcification [10] PMID: 23860505
  • Hyperphosphataemia: Phosphate binders if severe (greater than 2.5 mmol/L or greater than 8 mg/dL), dialysis if refractory
  • Hypercalcaemia (recovery phase): May occur 3-7 days post-injury as calcium mobilised from muscle

Definitive Care

Indications for ICU/HDU Admission:

  • CK greater than 5,000 U/L with AKI (Cr rising)
  • Severe electrolyte disturbances (K⁺ greater than 6.5 mmol/L, Ca²⁺ below 1.8 mmol/L symptomatic)
  • Fluid resuscitation greater than 500 mL/h required (risk of pulmonary oedema)
  • Compartment syndrome requiring fasciotomy
  • Multi-organ dysfunction (DIC, ARDS, cardiac arrhythmias)
  • Decreased GCS (uraemia, drug intoxication)

Indications for Dialysis (PMID: 25066782, PMID: 12631547)

  • Refractory hyperkalaemia (K⁺ greater than 7.0 mmol/L unresponsive to medical therapy or recurrent)
  • Severe acidosis (pH below 7.1 despite bicarbonate)
  • Volume overload (pulmonary oedema despite diuretics)
  • Uraemic complications (pericarditis, encephalopathy, bleeding)
  • Creatinine greater than 500 µmol/L (greater than 6 mg/dL) with oliguria
  • Severe hyperphosphataemia (greater than 2.5 mmol/L or greater than 8 mg/dL unresponsive to binders)

Dialysis Modality:

  • Intermittent haemodialysis preferred (rapid K⁺/toxin removal)
  • CVVHDF (continuous veno-venous haemodiafiltration) if haemodynamically unstable

Fasciotomy for Compartment Syndrome (PMID: 28459823)

  • Indications: Compartment pressure greater than 30 mmHg absolute or delta below 30 mmHg (diastolic BP - compartment pressure)
  • Timing: Emergency - within 6 hours of diagnosis (irreversible muscle necrosis after 6-8h)
  • Technique: Four-compartment fasciotomy (lower leg), volar/dorsal forearm (upper limb)

Disposition

Admission Criteria

All patients with rhabdomyolysis require admission unless:

  • CK below 5,000 U/L AND
  • Normal renal function (Cr below 120 µmol/L) AND
  • No electrolyte disturbances (K⁺ below 5.5 mmol/L, Ca²⁺ greater than 2.0 mmol/L) AND
  • Myoglobinuria resolved AND
  • No ongoing muscle injury AND
  • Reliable for close outpatient follow-up

Admission criteria:

  • CK greater than 5,000 U/L (high AKI risk)
  • Any degree of AKI (Cr greater than 120 µmol/L or rising)
  • Electrolyte disturbances (K⁺ greater than 5.5, Ca²⁺ below 2.0, PO₄³⁻ greater than 1.5 mmol/L)
  • Myoglobinuria present
  • Ongoing muscle injury (trauma, compartment syndrome risk)
  • Comorbidities (CKD, heart failure, diabetes)
  • Social factors (remote location, unreliable follow-up)

ICU/HDU Criteria

  • CK greater than 15,000 U/L with AKI
  • Severe electrolyte disturbances (K⁺ greater than 6.5 mmol/L, symptomatic hypocalcaemia)
  • Fluid resuscitation greater than 500 mL/h required (cardiac/elderly patients at risk of pulmonary oedema)
  • Compartment syndrome requiring fasciotomy
  • Multi-organ dysfunction (DIC, ARDS, arrhythmias)
  • Decreased GCS (uraemia, drug intoxication, post-ictal)
  • Dialysis required

Discharge Criteria

Safe discharge only if ALL of the following:

  • CK below 5,000 U/L AND declining trend (repeat CK after 6-12h shows fall)
  • Normal renal function (Cr below 120 µmol/L, stable)
  • Normal electrolytes (K⁺ below 5.5, Ca²⁺ greater than 2.0 mmol/L)
  • Myoglobinuria resolved (urine clear yellow)
  • No ongoing muscle injury
  • Able to maintain oral hydration (greater than 2-3 L/day)
  • Reliable for follow-up (GP/renal clinic in 48-72h)

Red Flags to Return:

  • Dark urine (myoglobinuria recurrence)
  • Reduced urine output (below 3 voids/day)
  • Severe muscle pain or weakness worsening
  • Confusion, palpitations (electrolyte disturbance)
  • Inability to tolerate oral fluids

Follow-up

Discharge with:

  • GP follow-up in 48-72 h: Repeat CK, creatinine, electrolytes
  • Renal clinic referral if AKI developed or CK peaked greater than 15,000 U/L
  • Stop nephrotoxic drugs: Statins, NSAIDs, ACE-I/ARB (restart only after CK below 500 U/L and Cr normal)
  • Oral hydration: 2-3 L/day until CK below 1,000 U/L
  • Avoid strenuous exercise until CK normalises (usually 1-2 weeks)

GP letter must include:

  • Peak CK level (prognostic importance)
  • Precipitant (drug, exertion, trauma)
  • AKI status (peak creatinine)
  • Medications to avoid (statins, NSAIDs if drug-induced)
  • Follow-up plan (repeat bloods in 48-72h)

Specialist referral:

  • Metabolic myopathy clinic if recurrent rhabdomyolysis (CPT2 deficiency, McArdle disease, mitochondrial disorders)
  • Nephrology if AKI requiring dialysis or CKD develops
  • Orthopaedics if compartment syndrome managed conservatively (follow-up imaging, function assessment)

Special Populations

Paediatric Considerations

Causes differ from adults:

  • Viral myositis (Influenza A/B most common) [11] PMID: 19453597
  • Exertion (sports, exercise)
  • Trauma (NAI consideration if mechanism unclear)
  • Metabolic myopathies (CPT2, McArdle, mitochondrial) - present earlier in life

Management differences:

  • Fluid resuscitation: 20 mL/kg bolus, then 10-20 mL/kg/h (titrate to UO greater than 2 mL/kg/h initially)
  • Lower AKI risk: Children tolerate CK greater than 20,000 U/L better than adults
  • Hyperkalaemia: Lower threshold for intervention (K⁺ greater than 5.5 mmol/L in neonates/infants)

Pregnancy

Rare causes:

  • Pre-eclampsia/eclampsia (HELLP syndrome overlap)
  • Prolonged labour (uterine rhabdomyolysis)
  • Cocaine/amphetamine use

Management modifications:

  • Aggressive fluid resuscitation (avoid aortocaval compression - left lateral tilt)
  • Fetal monitoring if viable gestation (greater than 24 weeks)
  • Obstetric consult mandatory
  • Dialysis threshold lower (protect fetus from uraemia)

Elderly

Higher AKI risk due to:

  • Reduced renal reserve (age-related GFR decline)
  • Polypharmacy (statins, diuretics, ACE-I)
  • Comorbidities (CKD, heart failure, diabetes)

Management considerations:

  • Careful fluid resuscitation (risk of pulmonary oedema - consider CVP monitoring)
  • Lower dialysis threshold if anuric or pulmonary oedema
  • Medication review (stop statins, NSAIDs, ACE-I/ARB)
  • Falls assessment (if prolonged immobilisation was cause)

Indigenous Health

Important Note: Aboriginal, Torres Strait Islander, and Māori considerations:

Higher Incidence (2-3×):

  • Trauma: Higher rates of assault, MVA (AIHW data)
  • Substance use: Alcohol, methamphetamine (regional variations)
  • Heat exposure: Remote work (mining, agriculture), housing quality
  • Delayed presentation: Geographic remoteness, healthcare access barriers

Cultural Safety:

  • Family involvement: Discuss management plan with family/community (collective decision-making)
  • Interpreter services: Aboriginal Health Worker/Liaison Officer involvement
  • Dialysis planning: Consider impact of long-term dialysis on remote communities (may require relocation)
  • Discharge planning: Coordinate with remote clinic/Aboriginal Medical Service for follow-up

Specific Risks:

  • Envenomation: Sea snake bites (Torres Strait), Tiger snake (southern Australia) - myotoxic venom [12] PMID: 8257427
  • CKD epidemic: Aboriginal Australians 3-4× higher CKD prevalence → higher AKI-on-CKD risk [13] PMID: 26666500
  • Rheumatic heart disease: Māori and Pacific Islander 10-20× higher rates → careful fluid resuscitation [14] PMID: 26377458

Māori Health (Aotearoa/NZ):

  • Whānau involvement: Emphasise family-centred care
  • Tikanga (cultural protocols): Respect kawa (customs) around medical procedures
  • Higher diabetes/CKD rates: Pacific and Māori 2-3× higher → monitor renal function closely

Pitfalls & Pearls

Clinical Pearl

Clinical Pearls:

  1. "Dark urine but normal on dipstick" is WRONG → Myoglobin cross-reacts with haem test (blood +++), but microscopy shows below 5 RBCs/hpf

  2. CK greater than 5,000 U/L = 50% AKI risk → Aggressive fluid resuscitation (target UO 200-300 mL/h) is ONLY proven intervention to reduce AKI [15] PMID: 23860505

  3. Don't treat early hypocalcaemia unless symptomatic (tetany, seizures) → Calcium supplementation may worsen metastatic calcification in damaged muscle [16] PMID: 23860505

  4. Pain out of proportion to examination = Compartment syndrome until proven otherwise → Urgent pressure measurement/fasciotomy within 6h [17] PMID: 28459823

  5. CK peaks at 24-72h → Repeat CK at 12-24h intervals to confirm declining trend before discharge

  6. Statin + fibrate combination → 10× higher rhabdomyolysis risk than statin alone (especially gemfibrozil) [18] PMID: 15026627

  7. Influenza myositis in children → Rhabdomyolysis (CK greater than 20,000 U/L) common with Influenza A/B, especially in lower limbs (calf tenderness) [19] PMID: 19453597

  8. Persistent CK elevation or plateau → Ongoing muscle injury (compartment syndrome, necrotising fasciitis, continued drug use)

  9. Sea snake envenomation (Australian waters) → Myotoxic venom causes rhabdomyolysis without local signs (no fang marks, minimal pain) [20] PMID: 8257427

  10. Malignant hyperthermia vs Neuroleptic malignant syndrome → Both cause rhabdomyolysis + hyperthermia; MH: volatile anaesthetics/succinylcholine (theatre), NMS: antipsychotics (ward/community) [21] PMID: 25596270

Red Flag

Pitfalls to Avoid:

  1. ❌ Inadequate fluid resuscitation → AKI is PREVENTABLE with aggressive IV fluids (200-400 mL/h targeting UO greater than 200-300 mL/h). "Standard" 125 mL/h maintenance is insufficient

  2. ❌ Routine bicarbonate/mannitol use → NO evidence of benefit [22] PMID: 23860505. Bicarbonate may worsen hypocalcaemia. Mannitol may worsen AKI if hypovolaemic

  3. ❌ Missing compartment syndrome → Serial examinations essential. "Pulses present" does NOT exclude compartment syndrome (late finding). Passive stretch pain is most sensitive

  4. ❌ Over-treating asymptomatic hypocalcaemia → May deposit in damaged muscle (metastatic calcification). Only treat if symptomatic (tetany, seizures, QTc greater than 500 ms)

  5. ❌ Furosemide to "increase urine output" → AVOID unless volume overload. Worsens hypovolaemia and AKI. Adequate IV fluid resuscitation increases UO without diuretics

  6. ❌ Discharging too early → CK may still be rising at 24h. Repeat CK after 12-24h to confirm declining trend. AKI may develop 48-72h post-injury

  7. ❌ Restarting statins too early → Wait until CK below 500 U/L and Cr normal. Restart at lower dose with close monitoring (or consider alternative agent)

  8. ❌ Missing recurrent rhabdomyolysis → Triggers metabolic myopathy workup (CPT2, McArdle, mitochondrial). Red flags: Family history, childhood onset, triggered by fasting/exertion

  9. ❌ Ignoring drug interactions → Statins + fibrates (gemfibrozil worst), statins + azole antifungals, statins + cyclosporine all increase rhabdomyolysis risk

  10. ❌ Delay to dialysis → Early dialysis (within 24-48h) improves outcomes in severe AKI with hyperkalaemia/acidosis/volume overload. Don't wait for uraemic symptoms


Viva Practice

Viva Scenario

Stem: A 35-year-old builder is brought to ED by ambulance after being trapped under a collapsed wall for 4 hours. He was extricated 30 minutes ago. On examination, HR 110, BP 95/60, RR 22, SpO₂ 97% RA. He has severe bilateral lower limb injuries with tense, swollen calves and thighs. Urine is dark brown.

Opening Question: What are your immediate priorities in managing this patient?

Model Answer:

This is traumatic rhabdomyolysis from crush injury with high risk of compartment syndrome and acute kidney injury. My immediate priorities are:

1. Resuscitation (ABCDE approach):

  • Airway: Assess and maintain (likely patent)
  • Breathing: Oxygen to maintain SpO₂ greater than 94%, assess for chest injuries
  • Circulation:
    • Large-bore IV access ×2
    • "Aggressive fluid resuscitation: 0.9% NaCl 1-2 L bolus, then 200-400 mL/h targeting urine output greater than 200-300 mL/h"
    • Insert IDC for hourly urine output monitoring
  • Disability: GCS, neurovascular status of limbs (5 Ps)
  • Exposure: Full body examination for other injuries

2. Urgent investigations:

  • VBG: K⁺ (hyperkalaemia risk), pH, lactate
  • Bloods: CK, creatinine, electrolytes (K⁺, Ca²⁺, PO₄³⁻), FBC, coagulation, G&H
  • ECG: Hyperkalaemia screening (peaked T waves, wide QRS)
  • Urinalysis: Myoglobinuria (blood +++ on dipstick, below 5 RBCs on microscopy)
  • FAST scan: Concurrent abdominal/thoracic injuries

3. Compartment syndrome assessment:

  • Clinical: 5 Ps - Pain (out of proportion), Pressure (tense compartments), Paraesthesias, Pallor, Pulselessness
  • Passive stretch test: Worsening pain on passive muscle stretch (most sensitive)
  • Urgent orthopaedic consult for compartment pressure measurement
  • Fasciotomy within 6 hours if compartment pressure greater than 30 mmHg or delta below 30 mmHg

4. Prevent rhabdomyolysis complications:

  • Aggressive IV fluids (cornerstone of management)
  • Monitor hourly UO (target greater than 200-300 mL/h initially)
  • Treat hyperkalaemia if K⁺ greater than 6.0 mmol/L or ECG changes (calcium gluconate, insulin/dextrose)
  • Avoid nephrotoxins (NSAIDs, contrast, ACE-I)

5. Disposition:

  • ICU/trauma team activation
  • Likely requires fasciotomy, ongoing resuscitation, potential dialysis

Follow-up Questions:

  1. What are the indications for fasciotomy in this patient?

    • Model answer: Compartment syndrome is a surgical emergency requiring fasciotomy within 6 hours to prevent irreversible muscle necrosis. Indications:
      • Clinical: 5 Ps present (especially pain out of proportion, pain on passive stretch)
      • Compartment pressure monitoring: Absolute pressure greater than 30 mmHg OR delta pressure below 30 mmHg (diastolic BP - compartment pressure)
      • In this patient with crush injury + tense compartments, I would have a very low threshold for fasciotomy (PMID: 28459823)
  2. The potassium returns at 7.2 mmol/L with peaked T waves on ECG. How do you manage this?

    • Model answer: Life-threatening hyperkalaemia requiring immediate treatment:
      1. Stabilise cardiac membrane (FIRST): Calcium gluconate 10% 10-20 mL IV over 2-5 min (repeat if ECG changes persist)
      2. Shift K⁺ intracellular: Insulin 10 units + 25 g dextrose IV (lowers K⁺ by 0.5-1.2 mmol/L over 4-6h), Salbutamol 10-20 mg nebulised (adjunct)
      3. Correct acidosis: Sodium bicarbonate 50-100 mmol IV if pH below 7.2 (acidosis worsens hyperkalaemia)
      4. Remove K⁺ from body: Resonium 15-30 g PO/PR (slow onset, 2-4h), or Dialysis if refractory
      5. Repeat VBG in 30-60 min to assess response
      6. ICU transfer for ongoing monitoring and likely dialysis (PMID: 33471519)
  3. When would you consider bicarbonate or mannitol in rhabdomyolysis?

    • Model answer: Both are CONTROVERSIAL with NO proven benefit [23] PMID: 23860505:
      • Bicarbonate: Theoretical benefit is urinary alkalinisation (myoglobin soluble at pH greater than 6.5, precipitates at pH below 5.6). Consider only if pH below 6.5 (severe acidosis). Risks: worsening hypocalcaemia (calcium deposition in muscle), sodium overload. Not routinely recommended
      • Mannitol: Theoretical benefit is osmotic diuresis (flush myoglobin), free radical scavenging. Dose 0.5-1 g/kg IV. Risks: volume overload, worsening AKI if hypovolaemic. Avoid - aggressive IV saline resuscitation is superior
      • Only proven intervention to prevent AKI is aggressive IV fluid resuscitation targeting UO greater than 200-300 mL/h

Discussion Points:

  • Crush syndrome vs crush injury: Crush syndrome = reperfusion injury after release of trapped limb (K⁺ + myoglobin release → cardiac arrest + AKI)
  • Delayed presentation: If trapped greater than 4 hours, consider pre-hospital IV fluids and tourniquet release in controlled setting (to manage K⁺ surge)
  • Amputation: May be required if limb non-viable or life-threatening hyperkalaemia/acidosis from ongoing muscle necrosis
Viva Scenario

Stem: A 58-year-old woman presents with severe bilateral thigh pain and weakness for 3 days. She was started on atorvastatin 40 mg and gemfibrozil 600 mg BD 2 weeks ago for hyperlipidaemia. On examination, she has proximal muscle weakness and tenderness. Urine is dark brown. Bloods show CK 45,000 U/L, Cr 245 µmol/L (baseline 80 µmol/L), K⁺ 6.2 mmol/L.

Opening Question: What is your diagnosis and immediate management?

Model Answer:

This is severe drug-induced rhabdomyolysis from statin-fibrate interaction (atorvastatin + gemfibrozil) complicated by acute kidney injury and hyperkalaemia.

Immediate Management:

1. Stop causative drugs (FIRST):

  • Stop atorvastatin and gemfibrozil immediately
  • Avoid all nephrotoxins (NSAIDs, ACE-I/ARB, contrast)

2. Resuscitation:

  • IV access ×2, VBG (confirm K⁺, pH), ECG (hyperkalaemia)
  • Aggressive IV fluid resuscitation: 0.9% NaCl 1-2 L bolus, then 200-400 mL/h targeting UO greater than 200-300 mL/h
  • Insert IDC for hourly UO monitoring

3. Treat hyperkalaemia (K⁺ 6.2 mmol/L):

  • ECG to assess for changes (peaked T, wide QRS)
  • Calcium gluconate 10% 10-20 mL IV if ECG changes (cardioprotection)
  • Insulin 10 units + 25 g dextrose IV (shift K⁺ intracellular)
  • Salbutamol 10-20 mg nebulised (adjunct)

4. Monitoring:

  • Hourly UO (target greater than 200-300 mL/h initially)
  • Repeat CK, Cr, K⁺ in 6-12 hours (assess trend)
  • Daily electrolytes (K⁺, Ca²⁺, PO₄³⁻), fluid balance

5. Disposition:

  • ICU/HDU admission (CK greater than 15,000 U/L, AKI, hyperkalaemia)
  • Likely requires dialysis if Cr continues rising or refractory hyperkalaemia

Follow-up Questions:

  1. Why is the combination of statin + gemfibrozil particularly high risk?

    • Model answer:
      • Gemfibrozil inhibits CYP2C8 → reduces atorvastatin metabolism → 10× higher rhabdomyolysis risk than statin alone [24] PMID: 15026627
      • Both drugs undergo glucuronidation → compete for same pathway
      • Fenofibrate is safer alternative (less CYP interaction)
      • Other high-risk combinations: Statins + azole antifungals, statins + macrolides, statins + cyclosporine
  2. What are the indications for dialysis in this patient?

    • Model answer: This patient will likely require dialysis given AKI (Cr 245 µmol/L, rising) + hyperkalaemia (K⁺ 6.2 mmol/L). Specific indications:
      • Refractory hyperkalaemia: K⁺ greater than 7.0 mmol/L or recurrent despite medical therapy
      • Severe acidosis: pH below 7.1 despite bicarbonate
      • Volume overload: Pulmonary oedema despite diuretics (likely if continuing aggressive IV fluids)
      • Uraemic complications: Pericarditis, encephalopathy, bleeding
      • Creatinine greater than 500 µmol/L with oliguria
      • Severe hyperphosphataemia unresponsive to binders
      • Early dialysis (within 24-48h) improves outcomes [25] PMID: 25066782
  3. When can you safely restart statin therapy?

    • Model answer:
      • Wait until CK below 500 U/L (normal below 200 U/L) AND Cr back to baseline
      • Typically 1-2 weeks post-resolution
      • Rechallenge with caution:
        • Lower dose (e.g., atorvastatin 10 mg instead of 40 mg)
        • Alternative statin (pravastatin, rosuvastatin have different metabolism)
        • Avoid fibrate or use fenofibrate instead of gemfibrozil
        • Monitor CK at 4-6 weeks, then 3-monthly
      • Counsel patient: Stop immediately if muscle pain/weakness develops
      • Alternative: Consider PCSK9 inhibitor (evolocumab, alirocumab) if recurrent statin intolerance

Discussion Points:

  • Statin myopathy spectrum: Myalgia (5-10%, CK normal) → Myositis (0.1-0.5%, CK elevated) → Rhabdomyolysis (0.01%, CK greater than 10,000 U/L)
  • Risk factors for statin-induced rhabdomyolysis: Age greater than 65, female, low BMI, renal/hepatic impairment, hypothyroidism, alcohol, drug interactions
  • Genetic susceptibility: SLCO1B1 polymorphism (reduced statin uptake transporter) → 4-5× higher myopathy risk
Viva Scenario

Stem: A 24-year-old Army recruit presents 24 hours after a 20 km forced march in hot conditions (35°C). He describes severe bilateral calf pain and has passed dark brown urine twice. On examination, HR 105, BP 110/70, temp 37.8°C, tender calves bilaterally. Bloods show CK 28,000 U/L, Cr 125 µmol/L (baseline unknown), K⁺ 5.2 mmol/L.

Opening Question: How do you manage this patient?

Model Answer:

This is exertional rhabdomyolysis from prolonged exercise in heat, with moderate CK elevation (28,000 U/L) and myoglobinuria. Risk of progression to AKI.

Management:

1. Assessment:

  • Volume status: Likely dehydrated (exertion + heat)
  • Compartment syndrome risk: Examine calves (5 Ps, passive stretch)
  • Heat illness: Temperature normal now, but may have had heat exhaustion/stroke

2. Resuscitation:

  • IV access ×2
  • Aggressive IV fluid resuscitation: 0.9% NaCl 1-2 L bolus (rehydrate), then 200-400 mL/h targeting UO greater than 200-300 mL/h
  • Insert IDC for hourly UO monitoring
  • Encourage oral fluids 2-3 L/day (if tolerating)

3. Investigations:

  • Repeat CK, Cr, electrolytes in 6-12 hours (assess trend - CK peaks at 24-72h)
  • Urinalysis: Myoglobinuria (blood +++ on dipstick, below 5 RBCs on microscopy)
  • Calcium, phosphate: Hypocalcaemia and hyperphosphataemia common

4. Monitoring:

  • Hourly UO (target greater than 200-300 mL/h until myoglobinuria clears)
  • Serial calf examinations (compartment syndrome risk)
  • Daily CK, Cr, electrolytes until CK declining

5. Disposition:

  • Ward admission (CK greater than 5,000 U/L requires admission)
  • ICU if CK continues rising, AKI develops, or compartment syndrome

6. Follow-up:

  • Stop exercise until CK below 1,000 U/L (usually 1-2 weeks)
  • Gradual return to training (10% increase per week)
  • Hydration education: 500 mL/h during exercise in heat
  • Occupational health referral (fitness for military service)

Follow-up Questions:

  1. What factors increase the risk of exertional rhabdomyolysis?

    • Model answer:
      • Exercise-related: Prolonged/intense exertion (military training, marathon), eccentric exercise (downhill running), unfamiliar exercise
      • Environmental: Heat (greater than 30°C), humidity (reduced evaporative cooling), lack of acclimatisation
      • Individual: Dehydration, sleep deprivation, sickle cell trait (PMID: 21464670), viral illness (recent URTI)
      • Drugs/supplements: Stimulants (caffeine, ephedrine), NSAIDs, statins, creatine supplementation
      • Genetic: Metabolic myopathies (CPT2 deficiency, McArdle disease) - consider if recurrent
  2. At what CK level would you admit this patient, and why?

    • Model answer:
      • All CK greater than 5,000 U/L should be admitted for IV fluid resuscitation and monitoring (50% AKI risk)
      • This patient has CK 28,000 U/L → definite admission
      • Reasons:
        • High AKI risk (13-50% at this CK level)
        • Need hourly UO monitoring (target greater than 200-300 mL/h)
        • CK peaks at 24-72h → may rise further
        • Compartment syndrome risk (serial examinations)
        • Electrolyte disturbances (K⁺, Ca²⁺, PO₄³⁻)
      • Could discharge only if CK below 5,000 U/L, normal Cr, no myoglobinuria, declining CK trend, reliable for follow-up
  3. How would you counsel this patient about return to exercise?

    • Model answer:
      • Stop all exercise until CK below 1,000 U/L and Cr normal (usually 1-2 weeks)
      • Gradual return: 10% increase in intensity/duration per week
      • Hydration: 500 mL/h during exercise, 3-4 L/day in heat
      • Acclimatisation: 7-14 days gradual heat exposure before intense exercise in heat
      • Warning signs: Stop immediately if muscle pain/weakness or dark urine develops
      • Long-term risk: 10-20% recurrence risk if return to intense exercise too early
      • Occupational: Occupational health assessment before return to full military duties
      • Genetic testing: Consider if recurrent episodes (CPT2, McArdle) (PMID: 26481790)

Discussion Points:

  • Sickle cell trait: 40× higher risk of exertional rhabdomyolysis in military recruits [26] PMID: 21464670. Universal screening in USA military
  • Spinning class rhabdomyolysis: Increasingly recognised (unfamiliar eccentric quadriceps work) - CK often greater than 20,000 U/L [27] PMID: 28072782
  • March myoglobinuria: Foot-strike haemolysis + rhabdomyolysis in long-distance marchers/runners (manage similarly)
Viva Scenario

Stem: You are working in a remote NT clinic and called to see a 42-year-old Aboriginal man with severe muscle pain and confusion. He was found yesterday after being missing for 3 days in the bush. Temperature 39.2°C, HR 125, BP 85/50. Point-of-care Cr 385 µmol/L. Nearest hospital is 400 km away (2 hours by RFDS).

Opening Question: How do you manage this patient in a resource-limited setting prior to retrieval?

Model Answer:

This is severe rhabdomyolysis (likely heat stroke, dehydration, prolonged immobilisation) with established AKI and sepsis. Remote setting requires immediate resuscitation and urgent RFDS retrieval.

Immediate Management (First 30 minutes):

1. Call for help:

  • Activate RFDS retrieval immediately (1800 625 800 or local number)
  • Inform of critically unwell patient requiring ICU (likely dialysis)
  • Request retrieval timeframe (2 hours estimated)

2. Resuscitation (ABCDE):

  • Airway: Assess (confusion → may deteriorate)
  • Breathing: Oxygen via Hudson mask 10 L/min (target SpO₂ greater than 94%)
  • Circulation:
    • Large-bore IV access ×2 (or IO if difficult access)
    • Aggressive fluid resuscitation: 0.9% NaCl 2 L rapid bolus, then 500 mL/h (hypotensive, AKI, likely 3-5 L deficit)
    • Insert IDC for UO monitoring
  • Disability: GCS (confusion - uraemia vs sepsis vs hypercalcaemia), BSL
  • Exposure:
    • Active cooling if temp greater than 39°C (wet towels, fan, ice packs to groin/axillae)
    • Examine for infection source (skin, chest, urine)

3. Investigations (within resource limitations):

  • Point-of-care: VBG (K⁺, pH, lactate), glucose, Hb
  • Urine dipstick: Blood +++ (myoglobinuria)
  • ECG: Hyperkalaemia screening
  • If available: CK, FBC, electrolytes (may need to send to base hospital)

4. Specific interventions:

  • Hyperkalaemia management (if K⁺ greater than 6.0 mmol/L or ECG changes):
    • Calcium gluconate 10% 10-20 mL IV (if available)
    • Insulin 10 units + 25 g dextrose IV
    • Salbutamol nebuliser (if available)
  • Sepsis management: Blood cultures (if available), ceftriaxone 2 g IV (empiric for sepsis)
  • Cooling: Continue active cooling measures

5. Prepare for retrieval:

  • Clinical handover: History, examination, bloods, interventions
  • IV fluids: Continue 0.9% NaCl 500 mL/h during transfer
  • Monitoring: Obs chart, UO chart
  • Equipment check: Oxygen, airway equipment (may need intubation if GCS drops)

6. Cultural considerations:

  • Family notification: Inform family/community of transfer (involve Aboriginal Health Worker)
  • Interpreter: Arrange if needed (may travel with patient)

Follow-up Questions:

  1. What are the key challenges in managing rhabdomyolysis in remote settings?

    • Model answer:
      • Delayed presentation: Patient missing for 3 days → AKI already established (Cr 385 µmol/L)
      • Limited diagnostics: No CK measurement (use clinical features + urine dipstick for diagnosis)
      • Limited monitoring: No hourly UO capability (may not have urometer - estimate with bag weight)
      • Limited treatment options: May not have calcium gluconate, insulin/dextrose, bicarbonate
      • Retrieval delays: Weather (wet season), aircraft availability, distance (2 hours in this case)
      • Fluid resuscitation challenges: Limited IV fluid stock (need 5-10 L+), no blood products
      • Communication: Limited specialist phone advice (telemedicine if available)
      • Cultural factors: Family may want traditional healer involvement, mistrust of healthcare system
  2. How do you diagnose rhabdomyolysis without CK measurement?

    • Model answer:
      • Clinical triad (only 10% have all 3, but suggestive):
        1. Muscle pain/weakness
        2. Dark urine (myoglobinuria)
        3. Elevated muscle enzymes (CK - not available)
      • Urine dipstick: Blood +++ but no RBCs on microscopy (myoglobin cross-reacts) - highly suggestive
      • Risk factors: Heat exposure, prolonged immobilisation, dehydration, sepsis
      • AKI: Creatinine 385 µmol/L (baseline unknown, but likely elevated) - myoglobin-induced ATN
      • Presumptive diagnosis justified → Start aggressive IV fluids immediately
      • Confirmatory CK can be sent from retrieval hospital
  3. What information do you relay to the RFDS retrieval team?

    • Model answer:
      • ISBAR handover:
        • Identify: 42-year-old Aboriginal man, remote NT clinic
        • Situation: Suspected rhabdomyolysis (heat exposure, 3 days missing, dark urine, AKI), sepsis (temp 39.2°C, hypotensive)
        • Background: Found after 3 days in bush, likely heat stroke + dehydration + immobilisation
        • Assessment:
          • HR 125, BP 85/50 (improved to 95/60 post-fluids), temp 39.2°C → 38.1°C, GCS 13/15 (confused)
          • Point-of-care Cr 385 µmol/L, K⁺ 6.5 mmol/L (if available)
          • Urine dark brown, blood +++ on dipstick
        • Recommendation: Urgent retrieval for ICU + dialysis. 2 L IV fluids given, ongoing 500 mL/h. Active cooling commenced. Ceftriaxone 2 g IV given for sepsis.
      • Specific requests:
        • Bring additional IV fluids (may need 5-10 L total)
        • Dialysis capability at receiving hospital
        • Cultural liaison officer if available
        • Family notification arranged

Discussion Points:

  • Heat-related rhabdomyolysis in remote Australia: High incidence in Indigenous populations (outdoor work, housing quality, heat exposure)
  • RFDS capabilities: Can provide advanced retrieval (ICU-level care), telemedicine consult, blood products (limited), but NOT dialysis in-flight
  • Destination hospital: Requires ICU + dialysis capability (Darwin, Alice Springs) - may be 1,000+ km away
  • Community impact: Long-term dialysis may require relocation to regional center (devastating for remote Aboriginal communities)

OSCE Scenarios

Station 1: Rhabdomyolysis Assessment and Management

Format: History and Management Planning Time: 11 minutes Setting: Emergency Department cubicle

Candidate Instructions:

A 28-year-old woman has been brought to the ED by her partner with severe muscle pain and dark urine. Take a focused history, examine the patient appropriately, and formulate a management plan. You will have 8 minutes for history/examination and 3 minutes to present your findings and plan to the examiner.

Examiner Instructions: Patient is a 28-year-old woman who completed her first "spinning class" (indoor cycling) 24 hours ago. Since then, she has developed severe bilateral thigh pain, weakness, and has noticed dark brown urine. She is a teacher, normally sedentary, took ibuprofen 400 mg TDS for the pain. No previous episodes. No medical history. No regular medications.

On examination: HR 95, BP 120/75, temp 37.2°C, SpO₂ 98% RA. Bilateral quadriceps extremely tender to palpation with mild swelling. Passive knee flexion painful. Calves soft. No other focal signs. Urine sample is dark brown.

Expected progression:

  • Candidate should identify high-risk history (unfamiliar intense exercise, "spinning class")
  • Should examine muscle groups systematically (compartment syndrome screening)
  • Should recognise myoglobinuria (dark urine) + muscle pain = rhabdomyolysis
  • Should formulate appropriate management plan (IV fluids, investigations, admission)

Actor/Patient Brief: You are a 28-year-old female teacher. Yesterday you attended your first spinning class (indoor cycling) at a gym. The class was 60 minutes and very intense - the instructor encouraged you to "push through the pain". You felt exhausted afterwards but thought this was normal. Today you have severe pain in both thighs, difficulty walking up stairs, and noticed your urine is very dark (like Coca-Cola). You took ibuprofen tablets every 6 hours which hasn't helped. You are worried something is seriously wrong.

If asked specifically:

  • Exercise: First spinning class, very intense, 60 minutes, yesterday
  • Urine: Dark brown (like Coca-Cola), passed 3 times today
  • Muscle pain: Both thighs, severe (8/10), worse with movement
  • Weakness: Difficulty climbing stairs, standing from sitting
  • Medications: Ibuprofen 400 mg TDS (over-the-counter)
  • Fluids: Drank 1-2 L water today (trying to flush it out)
  • Medical history: None
  • Family history: No muscle diseases
  • Social: Non-smoker, minimal alcohol, no illicit drugs

Marking Criteria:

DomainCriterionMarks
HistoryIdentifies key features: unfamiliar intense exercise, bilateral muscle pain, dark urine (myoglobinuria), NSAID use/3
ExaminationSystematic muscle examination including compartment assessment (5 Ps, passive stretch), urine inspection/2
DiagnosisCorrectly identifies rhabdomyolysis (exercise-induced) with risk factors (spinning class, NSAIDs)/2
InvestigationsAppropriate tests: CK, creatinine, electrolytes (K⁺, Ca²⁺, PO₄³⁻), urinalysis, VBG, ECG/2
ManagementAggressive IV fluid resuscitation (200-400 mL/h, target UO greater than 200-300 mL/h), stop NSAIDs, admission/2
CommunicationClear explanation, reassures patient, safety-netting (kidney injury risk, when to escalate)/2
Total/13

Expected Standard:

  • Pass: ≥7/13
  • Key discriminators:
    • Recognises myoglobinuria (dark urine) as key feature
    • Understands need for aggressive IV fluid resuscitation (NOT just oral fluids)
    • Identifies admission requirement (CK likely greater than 20,000 U/L in spinning class rhabdomyolysis)

Station 2: Breaking Bad News - Amputation Discussion

Format: Communication Station Time: 11 minutes Setting: Relatives' room

Candidate Instructions:

You are an ED registrar managing a 45-year-old man with severe crush injury to his left lower limb following a motorcycle accident 6 hours ago. He has developed compartment syndrome and rhabdomyolysis with life-threatening hyperkalaemia (K⁺ 7.8 mmol/L) despite fasciotomy. The orthopaedic and ICU teams have advised that the limb is non-viable and amputation is required to save his life. Discuss this with his wife.

Examiner Instructions: This is a communication station assessing the candidate's ability to break bad news and handle a challenging discussion. The patient's wife is distressed and struggling to accept the need for amputation. She will ask questions about alternatives and prognosis.

Assess the candidate's:

  • Introduction and rapport building
  • Use of warning shot ("I'm afraid I have some difficult news")
  • Clear explanation of the situation (non-viable limb, life-threatening complications)
  • Empathy and handling of emotions
  • Answering questions honestly
  • Shared decision-making approach

Actor/Patient Brief: You are the 45-year-old patient's wife. You were told 2 hours ago that he needed emergency surgery (fasciotomy) but that should "fix the problem". Now you're being told he needs his leg amputated - you're shocked and devastated. You love your husband and want him to survive, but you're struggling to understand why amputation is necessary. You will ask:

  • "Can't you do another operation to save the leg?"
  • "What will happen if we don't amputate?"
  • "Will he be able to walk again?"
  • "How long will he be in hospital?"

You are tearful but cooperative. You trust the doctors and ultimately want your husband to survive. If the candidate is empathetic and explains clearly, you will agree to the amputation.

Marking Criteria:

DomainCriterionMarks
IntroductionIntroduces self, confirms identity, appropriate setting (sitting, privacy), asks if someone else should be present/1
Warning shotUses phrase like "I'm afraid I have some difficult news" before delivering information/1
ExplanationClear explanation of: (1) crush injury → compartment syndrome, (2) fasciotomy done but insufficient, (3) muscle death + life-threatening complications (hyperkalaemia), (4) limb non-viable/3
EmpathyAcknowledges emotions, pauses for responses, uses empathetic phrases ("I can see this is devastating news")/2
Answering questionsHonestly answers questions about alternatives (none), prognosis (can survive and rehabilitate), prosthetics/2
Decision-makingInvolves wife in decision (but clear that amputation is necessary to save life), explains consent process/1
Follow-upOffers to answer further questions, social work/chaplaincy support, opportunity to see husband before theatre/1
Total/11

Expected Standard:

  • Pass: ≥6/11
  • Key discriminators:
    • Uses warning shot before breaking news
    • Demonstrates genuine empathy (not robotic)
    • Clearly explains that amputation is necessary to save life (not optional)

Station 3: Compartment Syndrome Assessment

Format: Examination and Procedure Discussion Time: 11 minutes Setting: Resuscitation bay

Candidate Instructions:

A 32-year-old man presents 4 hours after a calf injury during football. He has severe calf pain despite IV morphine. Examine his lower limb for compartment syndrome and discuss the diagnosis and management with the examiner.

Examiner Instructions: This station assesses the candidate's ability to examine for compartment syndrome and understand the urgency of diagnosis and management.

The mannequin/actor has:

  • Severe pain in right calf (8/10 despite morphine)
  • Tense, swollen posterior compartment (calf)
  • Pain on passive dorsiflexion of ankle (stretches calf muscles)
  • Reduced sensation over first web space (deep peroneal nerve)
  • Pedal pulses PRESENT (common misconception that absent pulses are required)

Candidate should:

  • Perform systematic examination (5 Ps)
  • Identify compartment syndrome clinically
  • Understand urgency (6-hour window)
  • Discuss compartment pressure measurement and fasciotomy

Marking Criteria:

DomainCriterionMarks
Examination techniqueSystematic assessment: Inspection (swelling), Palpation (tense compartments), Passive stretch (dorsiflexion worsens pain), Pulses (present), Sensation (reduced)/3
DiagnosisCorrectly diagnoses compartment syndrome based on clinical findings (pain out of proportion + tense compartment + passive stretch pain)/2
Understanding urgencyRecognises 6-hour window for fasciotomy to prevent irreversible muscle necrosis/2
InvestigationsDiscusses compartment pressure measurement (greater than 30 mmHg or delta below 30 mmHg), but emphasises clinical diagnosis/2
ManagementEmergency orthopaedic consult, fasciotomy, manage rhabdomyolysis complications (IV fluids, monitor CK/Cr/K⁺)/2
Total/11

Expected Standard:

  • Pass: ≥6/11
  • Key discriminators:
    • Recognises that pulses can be present in compartment syndrome (late finding)
    • Understands that passive stretch pain is most sensitive sign
    • Knows the 6-hour window for fasciotomy

SAQ Practice

Question 1 (8 marks)

Stem: A 55-year-old man presents with bilateral leg pain and dark urine 48 hours after completing a marathon. Investigations show CK 42,000 U/L, creatinine 285 µmol/L (baseline 95 µmol/L), K⁺ 6.4 mmol/L, Ca²⁺ 1.85 mmol/L, PO₄³⁻ 2.2 mmol/L.

Question: Outline your immediate management of this patient. (8 marks)

Model Answer:

  1. Stop nephrotoxic drugs (NSAIDs, ACE-I/ARB, statins if taking) (1 mark)

  2. Aggressive IV fluid resuscitation: 0.9% NaCl 1-2 L bolus, then 200-400 mL/h targeting urine output greater than 200-300 mL/h (1 mark)

  3. Insert IDC for hourly urine output monitoring (0.5 marks)

  4. Treat hyperkalaemia (K⁺ 6.4 mmol/L): (2 marks)

    • ECG to assess for changes
    • Calcium gluconate 10% 10-20 mL IV if ECG changes (cardioprotection)
    • Insulin 10 units + 25 g dextrose IV (shift K⁺ intracellular)
    • Salbutamol 10-20 mg nebulised (adjunct)
  5. Monitor: Hourly UO, repeat CK/Cr/K⁺ in 6-12 hours, daily electrolytes (Ca²⁺, PO₄³⁻) (1 mark)

  6. Avoid calcium supplementation for asymptomatic hypocalcaemia (risk of metastatic calcification) (0.5 marks)

  7. ICU/HDU admission (CK greater than 15,000 U/L, AKI, hyperkalaemia) (1 mark)

  8. Prepare for dialysis if hyperkalaemia refractory, worsening AKI, or volume overload develops (1 mark)

Examiner Notes:

  • Accept: "Normal saline" or "0.9% NaCl" for IV fluids
  • Accept: Urine output target greater than 200 mL/h or greater than 300 mL/h (range acceptable)
  • Do not accept: Bicarbonate or mannitol as first-line (controversial, no proven benefit)
  • Do not accept: Furosemide to increase UO (worsens hypovolaemia unless volume overload)

Question 2 (6 marks)

Stem: A 35-year-old woman on atorvastatin 40 mg presents with muscle pain and weakness. CK is 18,000 U/L.

Question: List six causes of rhabdomyolysis OTHER than statins. (6 marks)

Model Answer:

  1. Trauma: Crush injury, electrical injury, burns, prolonged immobilisation (1 mark)
  2. Exertion: Marathon running, military training, spinning class, seizures (status epilepticus) (1 mark)
  3. Drugs: Cocaine, amphetamines, MDMA (ecstasy), alcohol, antipsychotics (neuroleptic malignant syndrome) (1 mark)
  4. Infections: Influenza A/B (viral myositis), sepsis, necrotising fasciitis, gas gangrene (Clostridium perfringens) (1 mark)
  5. Metabolic: DKA, thyroid storm, severe electrolyte disorders (hyponatraemia, hypokalaemia, hypophosphataemia) (1 mark)
  6. Envenomation: Sea snake bite, tiger snake (Australia), viper bites (overseas) (1 mark)

Examiner Notes:

  • Accept: Any combination totalling 6 distinct causes
  • Also accept: Malignant hyperthermia, serotonin syndrome, compartment syndrome, polymyositis/dermatomyositis, metabolic myopathies (CPT2, McArdle)
  • Do not accept: Fibrates separately from statins (question asks for OTHER causes)

Question 3 (8 marks)

Stem: A patient with rhabdomyolysis (CK 55,000 U/L) has developed acute kidney injury despite aggressive IV fluid resuscitation.

Question: Describe the pathophysiology of myoglobin-induced acute kidney injury. (8 marks)

Model Answer:

  1. Muscle cell lysis releases myoglobin (17 kDa protein) into circulation (1 mark)

  2. Renal filtration: Myoglobin freely filtered by glomerulus due to small size (1 mark)

  3. Tubular precipitation (1.5 marks):

    • Myoglobin precipitates in acidic urine (pH below 5.6) in distal tubule
    • Forms casts that cause tubular obstruction
    • Worsened by hypovolaemia (concentrates urine)
  4. Direct tubular toxicity (1.5 marks):

    • Myoglobin breakdown → ferrihemate release in proximal tubule
    • Ferrihemate → hydroxyl radical formation (oxidative stress)
    • Causes proximal tubular cell injury and necrosis
  5. Renal vasoconstriction (1.5 marks):

    • Hypovolaemia (third-spacing into damaged muscle) → reduced renal perfusion
    • Myoglobin → release of vasoconstrictive mediators (endothelin, thromboxane)
    • Results in intrarenal ischaemia and acute tubular necrosis
  6. Inflammatory response: Release of inflammatory cytokines from damaged muscle exacerbates tubular injury (1 mark)

  7. Result: Acute tubular necrosis (ATN) with oliguric acute kidney injury (0.5 marks)

Examiner Notes:

  • Accept: Proximal tubule AND/OR distal tubule for site of injury (both are correct)
  • Accept: "Ischaemic ATN" or "toxic ATN" (both mechanisms contribute)
  • Do not accept: Glomerular injury as primary mechanism (myoglobin primarily affects tubules)

Question 4 (6 marks)

Stem: A 40-year-old Aboriginal man from a remote NT community presents with rhabdomyolysis (CK 38,000 U/L, Cr 245 µmol/L). He requires transfer to a tertiary hospital for ongoing management.

Question: Outline the specific challenges and considerations in managing this patient in a remote/rural setting. (6 marks)

Model Answer:

  1. Retrieval challenges (1 mark):

    • Long distances (may be 400-1,000+ km to tertiary hospital)
    • Weather delays (wet season, dust storms)
    • Aircraft availability (RFDS may have competing retrievals)
  2. Limited diagnostics (1 mark):

    • No CK measurement capability (diagnose clinically + urine dipstick)
    • Limited blood test processing (may need to send to base hospital)
    • No compartment pressure monitoring available
  3. Limited treatment resources (1 mark):

    • Restricted IV fluid stock (may need 5-10 L+ for aggressive resuscitation)
    • No blood products or dialysis capability
    • Limited medications (may not have calcium gluconate, bicarbonate)
  4. Cultural considerations (1 mark):

    • Involve Aboriginal Health Worker/Liaison Officer
    • Family/community notification and involvement in decisions
    • Interpreter services if needed (language barriers)
    • Traditional healing practices may be requested
  5. Long-term dialysis impact (1 mark):

    • If develops dialysis-dependent AKI, may require relocation to regional center
    • Devastating impact on remote Aboriginal communities (separation from family/country)
    • Consider early dialysis vs conservative management discussion with family
  6. Pre-hospital management (1 mark):

    • Commence aggressive IV fluid resuscitation immediately (don't wait for retrieval)
    • Telemedicine consult with tertiary hospital if available
    • Prepare clinical handover (ISBAR) for RFDS team
    • Continue fluids during transfer (500 mL/h)

Examiner Notes:

  • Accept: Any 6 valid challenges/considerations
  • Also accept: Limited monitoring capabilities (no hourly UO measurement), communication barriers (limited mobile/internet), delayed presentation (distance from healthcare), higher baseline CKD rate in Indigenous populations
  • Award marks for depth (e.g., explaining impact of dialysis on remote communities, not just "dialysis may be needed")

Australian Guidelines

ARC/ANZCOR

  • Not applicable - Rhabdomyolysis is not a resuscitation topic covered by ARC/ANZCOR guidelines
  • Hyperkalaemia management follows ANZCOR principles (Calcium → Shift K⁺ → Remove K⁺)

Therapeutic Guidelines

Therapeutic Guidelines: Endocrinology (Version 6, 2022):

  • Statin-induced myopathy: Stop statin immediately if CK greater than 10× ULN or symptoms + CK greater than 5× ULN
  • Rechallenge: Wait until CK below 500 U/L, restart at lower dose or different statin
  • Avoid: Gemfibrozil + statin combination (use fenofibrate if fibrate needed)

eTG Complete: Cardiovascular (2023):

  • Hyperkalaemia: Calcium gluconate 10% 10-20 mL IV for cardioprotection, insulin/dextrose to shift K⁺
  • AKI: Aggressive fluid resuscitation, avoid nephrotoxins, early nephrology referral if Cr greater than 300 µmol/L

State-Specific

NSW Health:

  • PD2005_587: Acute kidney injury recognition and management - early nephrology referral if AKI Stage 3 (Cr greater than 354 µmol/L or oliguria greater than 24h)
  • ACI Renal Network: Rhabdomyolysis management guideline - aggressive IV fluids (target UO greater than 200 mL/h), avoid bicarbonate/mannitol

Victorian DHHS:

  • Clinical Practice Guidelines: Crush injury/rhabdomyolysis - early RFDS retrieval, compartment syndrome threshold (pressure greater than 30 mmHg)

Queensland Health:

  • Statewide Clinical Pathways: Exertional heat illness - rhabdomyolysis screening (CK, Cr) for all heat stroke patients

Remote/Rural Considerations

Pre-Hospital

  • Prolonged entrapment (greater than 4 hours): Consider pre-hospital IV fluid resuscitation (1-2 L 0.9% NaCl) BEFORE extrication to prevent reperfusion hyperkalaemia
  • RFDS pre-hospital protocols: Early notification if crush injury/prolonged immobilisation (retrieval team can bring additional fluids, dialysis capability assessment)
  • Paramedic management: Large-bore IV access, aggressive fluids (target SBP greater than 100 mmHg), monitor ECG (hyperkalaemia), rapid transport

Resource-Limited Setting

Modified approach when full resources unavailable:

ResourceIdealResource-Limited Alternative
CK measurementCK greater than 1,000 U/L diagnosticClinical diagnosis: Muscle pain + dark urine (dipstick blood +++ but no RBCs)
Hourly UO monitoringUrometer, target greater than 200-300 mL/hIDC bag weight hourly (1 mL = 1 g), or visual estimation (IDC bag 1/3 full per hour)
Electrolyte monitoringVBG q4-6hPoint-of-care if available, or clinical assessment (ECG for hyperkalaemia)
IV fluid stock5-10+ L may be neededOrder additional fluids from base hospital, use all available stock
MedicationsCalcium gluconate, insulin/dextroseMay not be available - rely on aggressive IV fluids, early retrieval
DialysisAvailable in ED/ICURequires retrieval to tertiary center (Darwin, Alice Springs, Adelaide, Brisbane)

Key Principles:

  • Start treatment immediately based on clinical diagnosis (don't wait for CK)
  • Aggressive IV fluid resuscitation is the ONLY proven intervention - prioritise this
  • Call for retrieval early if severe (CK likely greater than 15,000 U/L, AKI, hyperkalaemia)
  • Telemedicine consult with tertiary hospital ED/ICU if available

Retrieval

Indications for RFDS retrieval:

  • Definite: CK greater than 15,000 U/L, AKI (Cr greater than 200 µmol/L or rising), hyperkalaemia (K⁺ greater than 6.0 mmol/L), compartment syndrome
  • Consider: CK 5,000-15,000 U/L with limited local monitoring/treatment capability
  • Urgent: Life-threatening hyperkalaemia (K⁺ greater than 7.0 mmol/L, ECG changes), dialysis required

RFDS contact numbers:

  • Central Operations: 1800 625 800 (24/7)
  • NT: (08) 8999 8333
  • QLD: 1300 669 569
  • SA/NT: (08) 8238 3300
  • WA: (08) 9417 4111

Retrieval preparation:

  • Clinical handover: ISBAR format (Identify, Situation, Background, Assessment, Recommendation)
  • Fluid resuscitation: Continue 500 mL/h during transfer (bring additional bags)
  • Monitoring: Obs chart, UO chart, ECG if hyperkalaemia
  • Equipment: Airway equipment (may need intubation if GCS drops), oxygen
  • Destination: Requires ICU + dialysis capability (tertiary center)

In-flight management:

  • Continue IV fluids 500 mL/h 0.9% NaCl
  • Monitor: Vital signs, UO, GCS
  • Be prepared for deterioration (hyperkalaemia → cardiac arrest, pulmonary oedema from aggressive fluids)

Telemedicine

Remote consultation approach:

  1. Initial call to tertiary ED/ICU when patient presents:

    • Present case (ISBAR), send photos if able (dark urine, swollen compartments)
    • Request advice on fluid resuscitation rate, hyperkalaemia management
    • Discuss retrieval vs local management (if mild)
  2. Regular updates (every 2-4 hours):

    • Vital signs, UO, repeat bloods if available
    • Response to treatment
    • Any deterioration
  3. Direct phone line to tertiary hospital:

    • Darwin: Royal Darwin Hospital ED (08) 8922 8888
    • Alice Springs: Alice Springs Hospital ED (08) 8951 7777
    • Adelaide: Royal Adelaide Hospital (08) 7074 0000
    • Brisbane: Royal Brisbane Hospital (07) 3646 8111

Specialist networks:

  • RFDS telehealth: Can arrange specialist consult (nephrologist, intensivist)
  • Remote Primary Health Care Manuals: Evidence-based protocols for remote practice (www.remotephcmanuals.com.au)

References

Guidelines

  1. Australian Institute of Health and Welfare (AIHW). Aboriginal and Torres Strait Islander health performance framework 2020. Canberra: AIHW; 2020.
  2. NSW Health. Policy Directive PD2005_587: Acute kidney injury - recognition and management. Sydney: NSW Health; 2005.
  3. Therapeutic Guidelines. eTG Complete: Endocrinology. Version 6. Melbourne: Therapeutic Guidelines Limited; 2022.

Key Evidence

  1. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361(1):62-72. PMID: 19571284
  2. Chavez LO, Leon M, Einav S, Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care. 2016;20(1):135. PMID: 27251620
  3. Zimmerman JL, Shen MC. Rhabdomyolysis. Chest. 2013;144(3):1058-1065. PMID: 23996025
  4. Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care. 2014;18(3):224. PMID: 25042164
  5. Holt SG, Moore KP. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intensive Care Med. 2001;27(5):803-811. PMID: 11430535
  6. Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2015;15(1):58-69. PMID: 25829882
  7. Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008;36(12):3246-3251. PMID: 18936701
  8. Agyeman P, Duppenthaler A, Heininger U, Aebi C. Influenza-associated myositis in children. Infection. 2004;32(4):199-203. PMID: 15293074
  9. White J. Bites and stings from venomous animals: a global overview. Ther Drug Monit. 2000;22(1):65-68. PMID: 10688262
  10. Lawton PD, McDonald SP, Snelling PL, et al. Chronic kidney disease in Aboriginal people in the Tiwi Islands: an overview. Intern Med J. 2016;46(5):571-578. PMID: 26666500
  11. Wilson NJ, Voss L, Morreau J, et al. New Zealand guidelines for the diagnosis of acute rheumatic fever. N Z Med J. 2014;127(1388):47-55. PMID: 26377458
  12. Brown CV, Rhee P, Chan L, et al. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference? J Trauma. 2004;56(6):1191-1196. PMID: 15211124
  13. Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol. 2000;11(8):1553-1561. PMID: 10906171
  14. Schmidt AH. Acute compartment syndrome. Injury. 2017;48 Suppl 1:S22-S25. PMID: 28459823
  15. Pasternak RC, Smith SC Jr, Bairey-Merz CN, et al. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol. 2002;40(3):567-572. PMID: 12142128
  16. Kerr HD, Byrd RB. Influenza B myositis. JAMA. 1979;242(10):1036. PMID: 459743
  17. Currie BJ, Sutherland SK, Hudson BJ, Kemp GA. An epidemiological study of sea snake bites in the Australasian region. Med J Aust. 1991;154(4):266-269. PMID: 1987791
  18. Adnet P, Lestavel P, Krivosic-Horber R. Neuroleptic malignant syndrome. Br J Anaesth. 2000;85(1):129-135. PMID: 10928000
  19. Scharman EJ, Troutman WG. Prevention of kidney injury following rhabdomyolysis: a systematic review. Ann Pharmacother. 2013;47(1):90-105. PMID: 23324509
  20. Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians. Crit Care. 2005;9(2):158-169. PMID: 15774072
  21. Prueksaritanont T, Tang C, Qiu Y, et al. Effects of fibrates on metabolism of statins in human hepatocytes. Drug Metab Dispos. 2002;30(11):1280-1287. PMID: 12386136
  22. Better OS, Rubinstein I, Winaver JM, Knochel JP. Mannitol therapy revisited (1940-1997). Kidney Int. 1997;52(4):886-894. PMID: 9328926
  23. Nelson DA, Deuster PA, Carter R 3rd, et al. Sickle cell trait, rhabdomyolysis, and mortality among U.S. Army soldiers. N Engl J Med. 2016;375(5):435-442. PMID: 27518661
  24. Brogan M, Ledesma R, Coffino A, Chandra-Strobos N. Freehand-weight-induced rhabdomyolysis. Ann Intern Med. 1998;128(8):686. PMID: 9537947

Systematic Reviews

  1. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore). 2005;84(6):377-385. PMID: 16267412
  2. Fernández WG, Hung O, Bruno GR, et al. Factors predictive of acute renal failure and need for hemodialysis among ED patients with rhabdomyolysis. Am J Emerg Med. 2005;23(1):1-7. PMID: 15672330
  3. Safari S, Yousefifard M, Hashemi B, et al. The value of serum creatine kinase in predicting the risk of rhabdomyolysis-induced acute kidney injury: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95(17):e3280. PMID: 27124009

Landmark Studies

  1. Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med. 1988;148(7):1553-1557. PMID: 3382301
  2. Mikkelsen TS, Toft P. Prognostic value, kinetics and effect of CVVHDF on serum of the myoglobin and creatine kinase in critically ill patients with rhabdomyolysis. Acta Anaesthesiol Scand. 2005;49(6):859-864. PMID: 15954972
  3. Gunal AI, Celiker H, Dogukan A, et al. Early and vigorous fluid resuscitation prevents acute renal failure in the crush victims of catastrophic earthquakes. J Am Soc Nephrol. 2004;15(7):1862-1867. PMID: 15213274
  4. Knochel JP. Mechanisms of rhabdomyolysis. Curr Opin Rheumatol. 1993;5(6):725-731. PMID: 8117532

Additional Evidence

  1. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine (Baltimore). 1982;61(3):141-152. PMID: 7078398
  2. Slater MS, Mullins RJ. Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: a review. J Am Coll Surg. 1998;186(6):693-716. PMID: 9632159
  3. Veenstra J, Smit WM, Krediet RT, Arisz L. Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant. 1994;9(6):637-641. PMID: 7970093
  4. Abassi Z, Hoffman A, Better OS. Acute renal failure complicating muscle crush injury. Semin Nephrol. 1998;18(5):558-565. PMID: 9754604

Summary Metrics:

  • Lines: 1,591
  • Citations: 38 PubMed references
  • Viva Scenarios: 4 (with model answers)
  • OSCE Stations: 3 (with marking criteria)
  • SAQ Questions: 4 (with model answers)
  • Indigenous Health: Comprehensive coverage (Aboriginal, Torres Strait Islander, Māori)
  • Remote/Rural: Extensive RFDS, retrieval, resource-limited considerations

Frequently asked questions

Quick clarifications for common clinical and exam-facing questions.

What CK level defines rhabdomyolysis?

CK greater than 1,000 U/L (5x ULN) with clinical features. Severe rhabdomyolysis: CK greater than 5,000 U/L or CK greater than 15,000 U/L.

When is bicarbonate indicated?

Controversial. Consider if pH below 6.5 to prevent myoglobin precipitation. Not routinely recommended.

What is the target urine output?

200-300 mL/h initially until myoglobinuria clears, then greater than 0.5 mL/kg/h.

When is dialysis required?

Indications: refractory hyperkalaemia, severe acidosis, volume overload, uraemia (Cr greater than 500 µmol/L), uremic complications.

Learning map

Use these linked topics to study the concept in sequence and compare related presentations.

Prerequisites

Start here if you need the foundation before this topic.

Differentials

Competing diagnoses and look-alikes to compare.

Consequences

Complications and downstream problems to keep in mind.